DarioHealth Corp.
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▼ -98.0% over 5Y.
today you would have $24.29▼ -97.6%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 10 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $11.38 | $15.72 | $34.40 | $85.60 | $259.40 | $285.80 | $131.20 | $15.52 | $32.04 | $65.00 | |
| P/E | 1.2x | 1.1x | 1.3x | 0.9x | 1.7x | 3.2x | 3.6x | 0.8x | 0.0x | 1.0x | 1.6x |
| P/S |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| EXOZExozymes Inc | $7.17 | — | 18.2x | — | -187.16% | $66.53M |
| RNTXRein Therapeutics, Inc. | $0.76 | — | — | — | -96.42% | $65.74M |
| GOSSGossamer Bio, Inc. | $10.99 | — | — | — | — | $67.22M |
| HYFTMindWalk Holdings Corp. | $1.39 |
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Company description provided by Yahoo Finance.
| 3.9x |
| 3.7x |
| 1.2x |
| 2.5x |
| 4.0x |
| 13.8x |
| 28.8x |
| 2.7x |
| 3.9x |
| 5.1x |
| 9.2x |
| P/B | 1.4x | 1.2x | 0.5x | 0.9x | 1.4x | 3.3x | 7.8x | 1.1x | 3.2x | 6.7x | — |
| EPS | $10.12 | $12.27 | $38.60 | $50.80 | $81.40 | $80.20 | $160.00 | $312.60 | $32.80 | $41.80 |
| Profit margin | -266.39% | -186.56% | -158.09% | -292.00% | -224.88% | -374.21% | -388.66% | -234.63% | -240.78% | -304.51% | -388.41% |
| ROE | -93.87% | -61.41% | -59.36% | -102.21% | -77.74% | -89.73% | -104.60% | -93.87% | -199.47% | -399.47% | — |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 7.6x |
| — |
| -85.38% |
| $65.31M |
| NNOXNano-X Imaging Ltd. | $0.83 | — | 0.5x | — | -50.12% | $65.2M |
| IBIOiBio, Inc. | $1.36 | — | 0.6x | — | -62.09% | $67.56M |